论文部分内容阅读
近年来前列腺癌在中国的发病率逐年上升,尤其对于超过60岁的男性。世界范围内,前列腺癌发病率在男性所有恶性肿瘤中位居第二。临床上前列腺癌主要治疗方法为根治性手术或放射治疗。而对于转移性前列腺癌或无法行根治性前列腺切除术和根治放射治疗的患者,内分泌治疗为首选治疗。而且近年来前列腺癌间歇性内分泌治疗的重要性及认可度逐渐提高,本文将对前列腺癌间歇性内分泌治疗最新的研究进展作一总结,以期为前列腺癌内分泌治疗提供新的思路。
In recent years, the incidence of prostate cancer in China increased year by year, especially for men over 60 years of age. Worldwide, the incidence of prostate cancer ranks second among all male malignancies. The main clinical treatment of prostate cancer is radical surgery or radiotherapy. For patients with metastatic prostate cancer or those who are unable to undergo radical prostatectomy and radical radiotherapy, endocrine therapy is the preferred treatment. And in recent years, the importance and recognition of intermittent endocrine therapy of prostate cancer gradually increased. This article summarizes the latest research progress of intermittent endocrine therapy of prostate cancer, in order to provide new ideas for endocrine therapy of prostate cancer.